H.R. 4184 · 119th Congress · Taxation

To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

In committee387 words Introduced Jun 26, 2025 · Latest action Jun 26, 2025

How far it has goneStage 2 of 6
  1. IntroducedJun 26, 2025 Done
  2. CommitteeReferred to Ways and Means Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 387 words

H.R. 4184 · Introduced in House · Jun 26, 2025

SECTION 1. EXCLUSION OF COMPENSATION PROVIDED TO PARTICIPANTS IN CLINICAL TRIALS.

(a) In general. Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section: 139J. Clinical trial payments (a) In general Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b) Qualified clinical trial payment defined For purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1) as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2) to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c) Other definitions For purposes of this section— (1) Approved clinical trial The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act ( 42 U.S.C. 300gg–8(d)(1) ), determined by applying disease or condition for life-threatening disease or condition . (2) Dependent The term dependent has the meaning given such term in section 152. .

(b) Clerical amendment. The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item: Sec. 139J. Clinical trial payments. .

(c) Effective date. The amendment made by this section shall apply to amounts paid after December 31, 2025.

SEC. 2. CLINICAL TRIAL COMPENSATION NOT TAKEN INTO ACCOUNT FOR PURPOSES OF DETERMINING ELIGIBILITY FOR FEDERAL PROGRAMS OR ASSISTANCE.

(a) In general. Notwithstanding any other provision of law, any amount received by an individual as a qualified clinical trial payment shall not be taken into account as income or resources for purposes of determining the eligibility of such individual (or any other individual) for benefits or assistance (or the amount or extent of benefits or assistance) under any Federal program or under any State or local program financed in whole or in part with Federal funds.

(b) Qualified clinical trial payment. For purposes of subsection (a), the term qualified clinical trial payment has the meaning given such term in section 139J(a) of the Internal Revenue Code of 1986 (as added by section 1 of this Act).

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

No lobbying filing on file names H.R. 4184.

Organizations that named H.R. 4184 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Jun 26, 2025Referred to the House Committee on Ways and Means.
  2. Jun 26, 2025Introduced in House